RELA and prostate carcinoma: As another example emerges, folic acid-conjugated gold nanoparticles to deliver functional siRNA was studied using RelA siRNA to silence RELA expression in prostate cancer cells, since this gene is one of the five gene products of NF-κB (nuclear factor-κB, a transcription factor found in many cancers) [45].